Global Pets NSAIDs Market Research Report 2025

Publication ID:

PB501251955

Publication Date:

January 22, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

The global market for Pets NSAIDs was valued at US$ 470 million in the year 2024 and is projected to reach a revised size of US$ 698 million by 2031, growing at a CAGR of 5.9% during the forecast period.
Veterinary nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly used to control fever, pain, and other signs of inflammation in animals. Inflammation is the body"s response to irritation or injury and results in redness, warmth, swelling, and pain in the inflamed area.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly 鈧�6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 43%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Pets NSAIDs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pets NSAIDs.
The Pets NSAIDs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pets NSAIDs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pets NSAIDs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Merck
Bayer
JandJ
GSK
Septodont
Roche
PerioChip
Mobic
Rimadyl
Vetprofen
Novox
Segment by Type
Injection Type
Oral Type
Others
Segment by Application
Pet Hospital
Pet Shop
Household Use
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pets NSAIDs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pets NSAIDs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Pets NSAIDs Market Overview
1.1 Product Definition
1.2 Pets NSAIDs by Type
1.2.1 Global Pets NSAIDs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Injection Type
1.2.3 Oral Type
1.2.4 Others
1.3 Pets NSAIDs by Application
1.3.1 Global Pets NSAIDs Market Value by Application (2024 VS 2031)
1.3.2 Pet Hospital
1.3.3 Pet Shop
1.3.4 Household Use
1.4 Global Pets NSAIDs Market Size Estimates and Forecasts
1.4.1 Global Pets NSAIDs Revenue 2020-2031
1.4.2 Global Pets NSAIDs Sales 2020-2031
1.4.3 Global Pets NSAIDs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Pets NSAIDs Market Competition by Manufacturers
2.1 Global Pets NSAIDs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Pets NSAIDs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Pets NSAIDs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Pets NSAIDs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pets NSAIDs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pets NSAIDs, Product Type & Application
2.7 Global Key Manufacturers of Pets NSAIDs, Date of Enter into This Industry
2.8 Global Pets NSAIDs Market Competitive Situation and Trends
2.8.1 Global Pets NSAIDs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Pets NSAIDs Players Market Share by Revenue
2.8.3 Global Pets NSAIDs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Pets NSAIDs Market Scenario by Region
3.1 Global Pets NSAIDs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Pets NSAIDs Sales by Region: 2020-2031
3.2.1 Global Pets NSAIDs Sales by Region: 2020-2025
3.2.2 Global Pets NSAIDs Sales by Region: 2026-2031
3.3 Global Pets NSAIDs Revenue by Region: 2020-2031
3.3.1 Global Pets NSAIDs Revenue by Region: 2020-2025
3.3.2 Global Pets NSAIDs Revenue by Region: 2026-2031
3.4 North America Pets NSAIDs Market Facts & Figures by Country
3.4.1 North America Pets NSAIDs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Pets NSAIDs Sales by Country (2020-2031)
3.4.3 North America Pets NSAIDs Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pets NSAIDs Market Facts & Figures by Country
3.5.1 Europe Pets NSAIDs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Pets NSAIDs Sales by Country (2020-2031)
3.5.3 Europe Pets NSAIDs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pets NSAIDs Market Facts & Figures by Region
3.6.1 Asia Pacific Pets NSAIDs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Pets NSAIDs Sales by Region (2020-2031)
3.6.3 Asia Pacific Pets NSAIDs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Pets NSAIDs Market Facts & Figures by Country
3.7.1 Latin America Pets NSAIDs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Pets NSAIDs Sales by Country (2020-2031)
3.7.3 Latin America Pets NSAIDs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pets NSAIDs Market Facts & Figures by Country
3.8.1 Middle East and Africa Pets NSAIDs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Pets NSAIDs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Pets NSAIDs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pets NSAIDs Sales by Type (2020-2031)
4.1.1 Global Pets NSAIDs Sales by Type (2020-2025)
4.1.2 Global Pets NSAIDs Sales by Type (2026-2031)
4.1.3 Global Pets NSAIDs Sales Market Share by Type (2020-2031)
4.2 Global Pets NSAIDs Revenue by Type (2020-2031)
4.2.1 Global Pets NSAIDs Revenue by Type (2020-2025)
4.2.2 Global Pets NSAIDs Revenue by Type (2026-2031)
4.2.3 Global Pets NSAIDs Revenue Market Share by Type (2020-2031)
4.3 Global Pets NSAIDs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Pets NSAIDs Sales by Application (2020-2031)
5.1.1 Global Pets NSAIDs Sales by Application (2020-2025)
5.1.2 Global Pets NSAIDs Sales by Application (2026-2031)
5.1.3 Global Pets NSAIDs Sales Market Share by Application (2020-2031)
5.2 Global Pets NSAIDs Revenue by Application (2020-2031)
5.2.1 Global Pets NSAIDs Revenue by Application (2020-2025)
5.2.2 Global Pets NSAIDs Revenue by Application (2026-2031)
5.2.3 Global Pets NSAIDs Revenue Market Share by Application (2020-2031)
5.3 Global Pets NSAIDs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Company Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Pets NSAIDs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Merck Pets NSAIDs Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Bayer
6.2.1 Bayer Company Information
6.2.2 Bayer Description and Business Overview
6.2.3 Bayer Pets NSAIDs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Bayer Pets NSAIDs Product Portfolio
6.2.5 Bayer Recent Developments/Updates
6.3 JandJ
6.3.1 JandJ Company Information
6.3.2 JandJ Description and Business Overview
6.3.3 JandJ Pets NSAIDs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 JandJ Pets NSAIDs Product Portfolio
6.3.5 JandJ Recent Developments/Updates
6.4 GSK
6.4.1 GSK Company Information
6.4.2 GSK Description and Business Overview
6.4.3 GSK Pets NSAIDs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 GSK Pets NSAIDs Product Portfolio
6.4.5 GSK Recent Developments/Updates
6.5 Septodont
6.5.1 Septodont Company Information
6.5.2 Septodont Description and Business Overview
6.5.3 Septodont Pets NSAIDs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Septodont Pets NSAIDs Product Portfolio
6.5.5 Septodont Recent Developments/Updates
6.6 Roche
6.6.1 Roche Company Information
6.6.2 Roche Description and Business Overview
6.6.3 Roche Pets NSAIDs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Roche Pets NSAIDs Product Portfolio
6.6.5 Roche Recent Developments/Updates
6.7 PerioChip
6.7.1 PerioChip Company Information
6.7.2 PerioChip Description and Business Overview
6.7.3 PerioChip Pets NSAIDs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 PerioChip Pets NSAIDs Product Portfolio
6.7.5 PerioChip Recent Developments/Updates
6.8 Mobic
6.8.1 Mobic Company Information
6.8.2 Mobic Description and Business Overview
6.8.3 Mobic Pets NSAIDs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Mobic Pets NSAIDs Product Portfolio
6.8.5 Mobic Recent Developments/Updates
6.9 Rimadyl
6.9.1 Rimadyl Company Information
6.9.2 Rimadyl Description and Business Overview
6.9.3 Rimadyl Pets NSAIDs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Rimadyl Pets NSAIDs Product Portfolio
6.9.5 Rimadyl Recent Developments/Updates
6.10 Vetprofen
6.10.1 Vetprofen Company Information
6.10.2 Vetprofen Description and Business Overview
6.10.3 Vetprofen Pets NSAIDs Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Vetprofen Pets NSAIDs Product Portfolio
6.10.5 Vetprofen Recent Developments/Updates
6.11 Novox
6.11.1 Novox Company Information
6.11.2 Novox Description and Business Overview
6.11.3 Novox Pets NSAIDs Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Novox Pets NSAIDs Product Portfolio
6.11.5 Novox Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pets NSAIDs Industry Chain Analysis
7.2 Pets NSAIDs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pets NSAIDs Production Mode & Process Analysis
7.4 Pets NSAIDs Sales and Marketing
7.4.1 Pets NSAIDs Sales Channels
7.4.2 Pets NSAIDs Distributors
7.5 Pets NSAIDs Customer Analysis
8 Pets NSAIDs Market Dynamics
8.1 Pets NSAIDs Industry Trends
8.2 Pets NSAIDs Market Drivers
8.3 Pets NSAIDs Market Challenges
8.4 Pets NSAIDs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Merck
Bayer
JandJ
GSK
Septodont
Roche
PerioChip
Mobic
Rimadyl
Vetprofen
Novox

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂